WeTrials
Recruiting

A Phase II, Open-label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (CANTOR)

What is this study?

This study is testing new combinations of medicines to treat colorectal cancer that has spread to other parts of the body. Researchers want to see how safe these new treatment options are and how well they work to fight the cancer.

Who can participate?

You might be able to join if you have been diagnosed with colon or rectum cancer that has spread, can still do your daily activities easily, and can share a tissue sample from your past medical care. People whose cancer has spread to the brain or who have certain other health conditions will not be able to take part.

What will happen?

Participants will receive study treatments, which may include immunotherapy to help your immune system fight the cancer, chemotherapy, or targeted therapies. Your health and your tumor's response to the treatment will be carefully monitored throughout the study.

Where and when?

This study is currently recruiting volunteers and has locations in Arizona, California, and Washington D.C., in the United States.

Key Points
  • 1Testing new treatment combinations for advanced colorectal cancer
  • 2Currently recruiting participants at select U.S. locations
  • 3Involves regular health monitoring and study medications like immunotherapy or chemotherapy

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Metastatic Colorectal Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.